Longevity – Page 2 – Infinite Unknown

Vitamin D prevents heart disease (… and 77% of all cancers)

November 25, 2009November 25, 2009 by Infinite

The sunshine vitamin

(NaturalNews) The fact that vitamin D prevents cancer is now so well known that even some conventional physicians are beginning to recommend it. Vitamin D prevents 77% of all cancers, after all. That’s as close to a “cure” for cancer as you’ll ever get (and it’s free, too, since you can make it yourself!).

But did you also know that vitamin D prevents heart disease? In fact, most people suffering from heart disease are chronically deficient in vitamin D. By correcting their vitamin D levels (through sunlight exposure or by taking vitamin D3 supplements), people can simultaneously halt cancer and prevent heart disease, too.

Here’s a collection of research revealing the amazing power of this “miracle” vitamin to eliminate heart disease. I’d like to add, though, that the previously recommended daily intake of 400 IUs of vitamin D is now considered hazardously low. Most nutritionally-aware doctors and naturopaths are now recommending anywhere from 1,000 – 4000 IUs per day of vitamin D supplementation. Of course, you don’t need any vitamin D supplements if you get sufficient sunlight on your skin on a regular basis.

Vitamin D prevents heart disease

Diabetes, both type-1 and type-2, are profoundly linked to low vitamin D levels. Obesity, heart disease, hypertension and stroke are inversely related to sunlight exposure and vitamin D levels. Psoriasis, eczema, and periodontal disease are lessened by sunlight exposure and high serum vitamin D. Fertility is positively influenced by sunlight exposure and high vitamin D levels. Sunlight enhances immune system function by producing vitamin D. Dozens of disorders other than those mentioned in this summary are related to vitamin D deficiency.
– Solar Power for Optimal Health by Marc Sorenson

Vitamin D supplements are likely to be useful in preventing diabetes in areas where vitamin D deficiency is common. In a 1997 study looking at the links between environmental factors and Type II diabetes, vitamin D levels were assessed in 142 Dutch men aged from 70 to 88 years of age. Thirty-nine per cent were found to have low vitamin D levels and tests showed that low vitamin D levels increased the risk of glucose intolerance. Heart disease: Low vitamin D levels may also increase the risk of atherosclerosis.
– The New Encyclopedia of Vitamins, Minerals, Supplements, and Herbs: How They Are Best Used to Promote Health and Well Being by Nicola Reavley

Easter Island Mystery: Scientists Say Natural Compound on Island Extends Lifespan

August 12, 2009 by Infinite

easter_island

(NaturalNews) No one can argue that Easter Island, located off the coast of Chile in the South Pacific, is one of the most mysterious places on earth. The extremely remote island is home to huge, enigmatic monoliths carved by the one-time inhabitants of the island who settled there over 1,500 years ago. The large-eyed stone figures stare out at the sea as if guarding a secret. Now scientists have uncovered another mystery of Easter Island — one that could be important for the future of humankind. New research suggests that a natural compound found in the soil of the island could be a health-promoting elixir of long life.

If this sounds like a fantasy or hocus pocus, it isn’t. In fact, a study of the compound was just published in the prestigious science journal Nature. Researchers say the biochemical, produced by soil bacteria, has such extraordinary life-extending properties it could lead to a genuine “anti-aging” pill that keeps people young.

Scientists at the University of Texas (UT) Health Science Center at San Antonio and collaborating centers at the University of Michigan at Ann Arbor and Jackson Laboratory in Bar Harbor, Maine, gave the Easter Island compound, which is called rapamycin after the island’s Polynesian name Rapa Nui, to middle-aged mice who were the equivalent, in mice years, of 60 year old people. The compound increased the animals’ expected by 28 percent to 38 percent. Place in human perspective, the scientists noted this increase in lifespan would be greater than the predicted increase in extra years of life if all cancers and heart disease could be prevented and cured.

“We believe this is the first convincing evidence that the aging process can be slowed…,” said Randy Strong, Ph.D., who directs the National Institute on Aging (NIA) funded Aging Interventions Testing Center in San Antonio. He is a professor of pharmacology at the UT Health Science Center and a senior research career scientist with the South Texas Veterans Health Care System.

Lifestyle Changes Boost Enzyme Regulating Cell Aging

September 17, 2008 by Infinite

TUESDAY, Sept. 16 (HealthDay News) — Major lifestyle changes can help improve levels of an enzyme called telomerase that controls cell aging, say California researchers.

Telomerase repairs and lengthens telomeres, which are DNA-protein complexes at the end of chromosomes that directly affect how quickly cells age. As telomeres become shorter and their structural integrity weakens, cells age and die more quickly, according to background information in a University of California, Irvine, new release. Shortening of telomeres is emerging as a marker of disease risk and premature death in many types of cancer, including prostate, lung, breast and colorectal cancers.

Moderate Exercise Greatly Extends Lifespan

August 12, 2008 by Infinite

(NaturalNews) A moderate increase in fitness level can decrease a man’s risk of dying by between 50 and 70 percent, according to a study conducted by the Exercise Testing and Research Lab at the Veterans Affairs Medical Center in Washington, and published in the journal Circulation.

Highly recommended:
– Ancient Secret of the Fountain of Youth (Book1) Great exercises!
– Ancient Secret of the Fountain of Youth (Book2)
– The Biology Of Belief
– The Wisdom of Your Cells
– Life and Teaching of the Masters of the Far East

Related article: Scientists stop the ageing process

“It is important to emphasize that it takes relatively moderate levels of physical activity – like brisk walking – to attain the associated health benefits,” said researcher Peter Kokkinos. “Certainly, one does not need to be a marathon runner. This is the message that we need to convey to the public.”

Researchers studied more than 15,000 male U.S. veterans, 6,749 black and 8,911 white. The men had been given standardized treadmill tests, in which they were encouraged to walk until they were tired, then monitored for an average of 7.5 years each.

Scientists stop the ageing process

August 11, 2008 by Infinite

There is more to life. The human body was not designed to “fall apart”.

Nobel Prize winner Dr. Alexis Carrel was able to keep cells from a chicken heart alive and replicating new cells for 28 years, far outliving the life of a chicken which is 7 to 12 years. The cells did not die of aging they simply terminated the experiment.

“The cell is immortal. It is merely the fluid in which it floats that degenerates. Renew this fluid at regular intervals, give the cell what it requires for nutrition, and as far as we know, the pulsation of life can go on forever.” – Dr. Alexis Carroll, Nobel Prize Winner

More here: (Health & Science) (Gesundheit & Wissenschaft)
___________________________________________________________________________

Clean bill of health: Scientists have shown that clearing damaged protein from the liver helps stop age decline in the organ (Source: iStockphoto)

Scientists have stopped the ageing process in an entire organ for the first time, a study released today says.

Published in today’s online edition of Nature Medicine, researchers at the Albert Einstein College of Medicine at Yeshiva University in New York City also say the older organs function as well as they did when the host animal was younger.

The researchers, led by Associate Professor Ana Maria Cuervo, blocked the ageing process in mice livers by stopping the build-up of harmful proteins inside the organ’s cells.

Tom Parr lived 152 Years

March 9, 2024June 23, 2008 by Infinite

Medicine: A Challenge to Tom Parr

Source: Time Magazine

In 1944 the American Medical Association gave its distinguished service medal to wiry, twinkle-eyed Dr. George Dock, of Pasadena, Calif. Last week at the Los Angeles County Medical Association Building, 300 physicians closer to home honored the 90-year-old doctor by turning out to attend the tenth annual George Dock lecture.

The old scholar, who has given up the practice of internal medicine to spend his days improving the Los Angeles County Medical Association library, could not get to the lecture this year: he was confined to his home with a mild case of dysentery. But he got a great deal of satisfaction in knowing that the meeting was well attended and that his colleagues were showing a very lively interest in the history of medicine.*

In at the Birth. The lecture series was begun ten years ago to honor Dr. Dock as any good physician would like most to be honored-by encouraging interest in his pet subject, medical history. But Historian Dock had never neglected the other four main areas of his profession-practice, writing, research and teaching.

To the younger physicians and medical students in last week’s audience, Dr. Dock seemed almost a relic of the last century. He was in fact one of the eagerly assisting midwives at the birth of modern medicine.

He graduated from the University of Pennsylvania’s Medical School in 1884, before the X ray was discovered. He was a student, and later an associate, of the great Sir William Osier, who died 30 years ago. He was one of the first men to recognize leukemia and Hodgkin’s disease as tumors rather than infections. He published the first successful diagnosis on a living patient of the disease now called coronary thrombosis, and made microscopic post-mortem sections of coronary arteries a full 25 years before the process was generally understood.

Out in the Clinic. Since 1888, Dr. Dock has contributed 158 papers to medical journals on an astonishing variety of subjects, the titles of which give a clue to his wry humor and firm thoroughness, e.g., The Advantage of Using Potassium Iodide Until We Have Something Better, Spelling As An Index to the Preparation of the Preparation of the Medical Student. He was one of the first full-time professors of medicine in the U.S. (at Washington University in St. Louis). As a precise, energetic professor at the University of Michigan until 1908, he was the first teacher willing to make the clinic rounds white-jacketed like his students, helped give the school its reputation as one of the country’s finest medical colleges.

Last year, when he was able to attend the ninth George Dock lecture, Dr. Dock, then a mere 89, told his colleagues: “I would like to live as long as Tom Parr.”

Nobody was sure who Tom Parr was, but Los Angeles Urologist Elmer Belt went searching through his medical books in the systematic way that Dr. Dock would appreciate. Finally, buried deep in a volume of The Works of William Harvey (discoverer of the circulatory system), Dr. Belt found a four-page chapter titled: Anatomical Examination Of The Body Of Thomas Parr. It began: “Thomas Parr, a poor countryman, born near Winnington, in the County of Salop [England] died on the 14th of November in the Year of Grace 1635, after having lived 152 years and nine months and survived nine princes.”

New Hints Seen That Red Wine May Slow Aging

June 16, 2008 by Infinite

Red wine may be much more potent than was thought in extending human lifespan, researchers say in a new report that is likely to give impetus to the rapidly growing search for longevity drugs.

The study is based on dosing mice with resveratrol, an ingredient of some red wines. Some scientists are already taking resveratrol in capsule form, but others believe it is far too early to take the drug, especially using wine as its source, until there is better data on its safety and effectiveness.

The report is part of a new wave of interest in drugs that may enhance longevity. On Monday, Sirtris, a startup founded in 2004 to develop drugs with the same effects as resveratrol, completed its sale to GlaxoSmithKline for $720 million.

Sirtris is seeking to develop drugs that activate protein agents known in people as sirtuins.

“The upside is so huge that if we are right, the company that dominates the sirtuin space could dominate the pharmaceutical industry and change medicine,” Dr. David Sinclair of the Harvard Medical School, a co-founder of the company, said Tuesday.

(And like always in these studies scientists want to isolate a miracle ingredient so that the corporations, “Big Pharma”, can sell it for a very high price and protect their profit monopole through a patent on it.

This the same completely backwards, unholistic approach that western medicine is using. An apple that has very little Vitamin C, but if you look at the synergy effect of those ingredients an apple is equivalent to 1500mg of Vitamin C! So trust nature.

And such News are always represented in an “Divide et Impera” way!

1-2 glasses Wine are just excellent for your health. – The Infinite Unknown)

Expect new drugs to treat aging, researchers say

June 5, 2008 by Infinite

Resveratrol, substance found in red wine, benefits health

NEW YORK — Is 90 the new 50?

Not yet, aging researchers say, but medical breakthroughs to significantly extend life and ease the ailments of getting older are closer than many people think.

“The general public has no idea what’s coming,” said David Sinclair, a Harvard Medical School professor who has made headlines with research into the health benefits of a substance found in red wine called resveratrol.

Speaking on a panel of aging experts, Sinclair had the boldest predictions. He said scientists can greatly increase longevity and improve health in lab animals like mice, and that drugs to benefit people are on the way.

“It’s not an if, but a when,” said Sinclair, who co-founded Sirtris Pharmaceuticals to pursue such drugs. The company, which is testing medicine in people with Type 2 diabetes, was recently bought for $720 million by GlaxoSmithKline, the world’s second-largest drug maker.